According to the customer: "two hours after the extracorporal circulation started at the cabg surgery, pa02 decreased to 130mmhg.The customer operated to increase fi02 from 65% to 70%, so that p02 increased to 266mmhg in the end.Stayed on the same device and continued the procedure.1 hour later, pa02 decreased again to 119mmhg before weaning, and p02 did not go up any more even if fi02 was adjusted 100%.The customer continued to use the device and the surgery was finished without any problem".No adverse effects on the patient (b)(4).
|
The product was visually inspected in the laboratory of the manufacturer.No clots were detected.The product was cleaned with sodium hypochlorite solution.No other abnormalities were detected.Affected product: basic lot 70113492 and packaging lot 70115550 (serial number (b)(4).The avz from geq 300 to geq 314 (b)(4) was reviewed on (b)(6) 2017.There were no references found, which are indicating a nonconformance of the product in question.Additionally a review of the weekly performance monitoring according to si-c-09 has been reviewed (b)(4), the performance tests passed the acceptance criteria.Thus the reported failure could not be confirmed.Based on the results obtained during investigation at this time the cause of the reported incident was determined to not be attributed to a device related malfunction.Since the reported failure did not contribute to a death or serious injury and no systemic issue could be determined no corrective action is needed at this time.
|